Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy
Front Pharmacol
.
2022 Nov 28:13:1081912.
doi: 10.3389/fphar.2022.1081912.
eCollection 2022.
Author
Tian Tian
1
Affiliation
1
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
PMID:
36518660
PMCID:
PMC9744131
DOI:
10.3389/fphar.2022.1081912
No abstract available
Keywords:
apoptosis; breast cancer; cell death; chemoresisitance; exon deletion.
Publication types
Comment